- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02060539
Multicenter Dispensing Study of Biofinity Lenses in Extended Range
8 novembre 2017 mis à jour par: CooperVision, Inc.
To obtain subjective and objective feedback on the clinical performance of Biofinity lenses after at least two weeks daily wear in existing contact lens wearers compared with their habitual lenses.
Aperçu de l'étude
Statut
Complété
Les conditions
Intervention / Traitement
Type d'étude
Interventionnel
Inscription (Réel)
19
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L 3G1
- CCLR, University of Waterloo
-
-
-
-
California
-
Berkeley, California, États-Unis, 94720-2020
- UC Berkeley Clinica Research Center
-
-
Indiana
-
Indianapolis, Indiana, États-Unis, 46266-6057
- CORL, Indiana University School of Optometry
-
-
Texas
-
Houston, Texas, États-Unis, 77204-2020
- TERTC, University of Houston
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
18 ans et plus (Adulte, Adulte plus âgé)
Accepte les volontaires sains
Non
Sexes éligibles pour l'étude
Tout
La description
Inclusion Criteria:
- Has had an oculo-visual examination in the last two years
- Is at least 18 years of age and has full legal capacity to volunteer
- Has read and understood the information consent letter
- Is willing and able to follow instructions and maintain the appointment schedule
- Is correctable to a visual acuity of 20/50 or better (in at least one eye) with their habitual vision correction
- Currently wears soft contact lenses
- They should require contact lens powers between -12.00 and -20.00D or between +8.00 and +15.00D
- Has clear corneas and no active ocular disease
- Demonstrates an acceptable fit with the study lenses.
Exclusion Criteria:
- Has any systemic disease affecting ocular health
- Is taking medication, such as antihistamine eye drops, oral and ophthalmic betaadrenergic blockers (e.g. Propanolol, Timolol), anticholinergics, and any prescribed or over-the-counter eye medication, except artificial tears or eye lubricants
- Have any active ocular disease and/or infection that would contraindicate contact lens wear.
- Active ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active.
- Has worn gas permeable contact lenses within the last month.
- Is aphakic
- Has undergone corneal refractive surgery.
- Is participating in any other type of clinical research study
- Female who is currently pregnant or is breast-feeding.
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Biofinity XR
Participants dispensed Biofinity XR lenses over two weeks of lens wear
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Dryness (During Day and Dryness at Night)
Délai: Baseline
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=cannot be worn, Extremely dry.
100=No dryness experienced at any time.)
Obtained habitual lens history at baseline.
|
Baseline
|
|
Dryness (During Day)
Délai: Dispense
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=cannot be worn, Extremely dry.
100=No dryness experienced at any time.)
Obtained at dispense; Lens pair one dispensed at the baseline visit and Lens pair two dispensed at 2 weeks visit.
|
Dispense
|
|
Dryness (During Day and Dryness at Night)
Délai: 2 Weeks
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=cannot be worn, Extremely dry.
100=No dryness experienced at any time.)
Obtained at two weeks.
|
2 Weeks
|
|
Comfort (Insertion, End of Day, Overall)
Délai: Baseline
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=cannot be worn,Causes pain; 100=Cannot be felt ever) Obtained habitual lens history at baseline.
|
Baseline
|
|
Comfort (Insertion)
Délai: Dispense
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=cannot be worn,Causes pain; 100=Cannot be felt ever) Obtained at dispense; Lens pair one dispensed at the baseline visit and Lens pair two dispensed at 2 weeks visit.
|
Dispense
|
|
Comfort (Insertion, End of Day, Overall)
Délai: 2 Weeks
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=cannot be worn,Causes pain; 100=Cannot be felt ever) Obtained at 2 weeks.
|
2 Weeks
|
|
Ghosting (Multiple Images)
Délai: Baseline
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=Extreame ghosting.
Cannot be worn.
100=No ghosting ever.)
Obtained habitual lens history at baseline.
|
Baseline
|
|
Ghosting (Multiple Images)
Délai: Dispense
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=Extreme ghosting.
Cannot be worn.
100=No ghosting ever.)
Obtained at dispense; Lens pair one dispensed at the baseline visit and Lens pair two dispensed at 2 weeks visit.
|
Dispense
|
|
Ghosting (Multiple Images)
Délai: 2 Weeks
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=Extreme ghosting.
Cannot be worn.
100=No ghosting ever.)
Obtained at 2 weeks.
|
2 Weeks
|
|
Hazing (Blurred Edges)
Délai: Baseline
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=Extreame haze.
Cannot be worn.
100=No hazing experienced at any time.)
Obtained habitual lens history at baseline.
|
Baseline
|
|
Hazing (Blurred Edges)
Délai: 2 Weeks
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=Extreme haze.
Cannot be worn.
100=No hazing experienced at any time.)
Obtained at 2 weeks.
|
2 Weeks
|
|
Vision Quality (During Day and at Night)
Délai: Baseline
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=Extremely poor vision all the time.
Cannot function; 100=Excellent vision all of the time.)
Obtained habitual lens history at baseline.
|
Baseline
|
|
Vision Quality (During Day)
Délai: Dispense
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=Extremely poor vision all the time.
Cannot function; 100=Excellent vision all of the time.)
Obtained at dispense; Lens pair one dispensed at the baseline visit and Lens pair two dispensed at 2 weeks visit.
|
Dispense
|
|
Vision Quality (During Day and at Night)
Délai: 2 Weeks
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=Extremely poor vision all the time.
Cannot function; 100=Excellent vision all of the time.)
Obtained at 2 weeks.
|
2 Weeks
|
|
Handling (Insertion, Removal, Overall)
Délai: Baseline
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=cannot be worn,Causes pain; 100=Cannot be felt ever) Obtained habitual lens history at baseline.
|
Baseline
|
|
Handling (Insertion, Removal, Overall)
Délai: 2 weeks
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=cannot be worn,Causes pain; 100=Cannot be felt ever) Obtained at 2 weeks.
|
2 weeks
|
|
Overall Satisfaction of Comfort, Vision, Handling
Délai: Dispense
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=Extremely dissatisfied; 100=Extremely satisfied.)
Obtained at dispense; Lens pair one dispensed at the baseline visit and Lens pair two dispensed at 2 weeks visit.
|
Dispense
|
|
Overall Satisfaction of Comfort, Vision, Handling
Délai: Baseline
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=Extremely dissatisfied; 100=Extremely satisfied.)
Obtained habitual lens history at baseline.
|
Baseline
|
|
Overall Satisfaction of Comfort, Vision, Handling
Délai: 2 Weeks
|
Subjective response of participant by questionnaire on a visual analog scale (0-100, 0=Extremely dissatisfied; 100=Extremely satisfied.)
Obtained at baseline at 2 weeks.
|
2 Weeks
|
|
Comfort Preference
Délai: Dispense
|
Subjective response of participant by questionnaire on a likert scale (Prefer New Lenses Strongly, Prefer New Lenses Slightly, No Preference - both acceptable/both unacceptable, Prefer My Own Lenses Slightly, Prefer My Own Lenses Strongly) Obtained at dispense; Lens pair one dispensed at the baseline visit and Lens pair two dispensed at 2 weeks visit.
|
Dispense
|
|
Comfort Preference
Délai: 2 Weeks
|
Subjective response of participant by questionnaire on a likert scale (Prefer New Lenses Strongly, Prefer New Lenses Slightly, No Preference - both acceptable/both unacceptable, Prefer My Own Lenses Slightly, Prefer My Own Lenses Strongly) Obtained at 2 weeks.
|
2 Weeks
|
|
Vision Preference
Délai: Dispense
|
Subjective response of participant by questionnaire on a likert scale (Prefer New Lenses Strongly, Prefer New Lenses Slightly, No Preference - both acceptable/both unacceptable, Prefer My Own Lenses Slightly, Prefer My Own Lenses Strongly) Obtained at dispense; Lens pair one dispensed at the baseline visit and Lens pair two dispensed at 2 weeks visit.
|
Dispense
|
|
Vision Preference
Délai: 2 Weeks
|
Subjective response of participant by questionnaire on a likert scale (Prefer New Lenses Strongly, Prefer New Lenses Slightly, No Preference - both acceptable/both unacceptable, Prefer My Own Lenses Slightly, Prefer My Own Lenses Strongly) Obtained at 2 weeks.
|
2 Weeks
|
|
Handling Preference
Délai: 2 Weeks
|
Subjective response of participant by questionnaire on a likert scale (Prefer New Lenses Strongly, Prefer New Lenses Slightly, No Preference - both acceptable/both unacceptable, Prefer My Own Lenses Slightly, Prefer My Own Lenses Strongly) Obtained at 2 weeks.
|
2 Weeks
|
|
Overall Preference
Délai: Dispense
|
Subjective response of participant by questionnaire on a likert scale (Prefer New Lenses Strongly, Prefer New Lenses Slightly, No Preference - both acceptable/both unacceptable, Prefer My Own Lenses Slightly, Prefer My Own Lenses Strongly) Obtained at dispense; Lens pair one dispensed at the baseline visit and Lens pair two dispensed at 2 weeks visit.
|
Dispense
|
|
Overall Preference
Délai: 2 Weeks
|
Subjective response of participant by questionnaire on a likert scale (Prefer New Lenses Strongly, Prefer New Lenses Slightly, No Preference - both acceptable/both unacceptable, Prefer My Own Lenses Slightly, Prefer My Own Lenses Strongly) Obtained at 2 weeks.
|
2 Weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Lens Centration - Habitual Lenses
Délai: Baseline
|
Objective measurement by investigator.
(Assessed as optimum, slightly decentered, extremely decentered) Obtained for habitual lenses at baseline.
|
Baseline
|
|
Lens Centration
Délai: Dispense
|
Objective measurement by investigator.
(Assessed as optimum, slightly decentered, extremely decentered) Obtained at baseline at dispense.
|
Dispense
|
|
Lens Centration
Délai: 2 Weeks
|
Objective measurement by investigator.
(Assessed as optimum, slightly decentered, extremely decentered) Obtained at 2 weeks.
|
2 Weeks
|
|
Lens Movement - Habitual Lenses
Délai: Baseline
|
Objective measurement by investigator of overall post-blink lens movement.
(Average Grade; Graded 0-4; 0=exceptionally tight, 2=optimal, 4=exceptionally loose) Obtained for habitual lenses at baseline.
|
Baseline
|
|
Lens Movement
Délai: Dispense
|
Objective measurement by investigator of overall post-blink lens movement.
(Average Grade; Graded 0-4; 0=exceptionally tight, 2=optimal, 4=exceptionally loose) Obtained at dispense; Lens pair one dispensed at the baseline visit and Lens pair two dispensed at 2 weeks visit.
|
Dispense
|
|
Lens Movement
Délai: 2 Weeks
|
Objective measurement by investigator of overall post-blink lens movement.
(Average Grade; Graded 0-4; 0=exceptionally tight, 2=optimal, 4=exceptionally loose) Obtained at 2 weeks wear.
|
2 Weeks
|
|
Overall Fit Acceptance
Délai: Baseline
|
Objective measurement by investigator of overall fit acceptance.
(scale 0-4; 0=very poor, 4=very good) Obtained for habitual lenses at baseline.
|
Baseline
|
|
Overall Fit Acceptance
Délai: Dispense
|
Objective measurement by investigator of overall fit acceptance.
(scale 0-4; 0=very poor, 4=very good) Obtained at dispense; Lens pair one dispensed at the baseline visit and Lens pair two dispensed at 2 weeks visit.
|
Dispense
|
|
Overall Fit Acceptance
Délai: 2 Weeks
|
Objective measurement by investigator of overall fit acceptance.
(scale 0-4; 0=very poor, 4=very good) Obtained at 2 weeks.
|
2 Weeks
|
|
Visual Acuity
Délai: Baseline
|
Objective measurement by investigator of monocular high and low contrast logMar visual acuity.
Visual Acuity High-Contrast (VA HC), Visual Acuity Low-Contrast (VA LC), Visual Acuity High-Contrast OU (VA HC OU), Visual Acuity Low-Contrast OU (VA LC OU).
Obtained for habitual lenses at baseline.
|
Baseline
|
|
Visual Acuity
Délai: Dispense
|
Objective measurement by investigator of monocular high and low contrast logMar visual acuity.
Visual Acuity High-Contrast (VA HC), Visual Acuity Low-Contrast (VA LC), Visual Acuity High-Contrast OU (VA HC OU), Visual Acuity Low-Contrast OU (VA LC OU).
Obtained at dispense; Lens pair one dispensed at the baseline visit and Lens pair two dispensed at 2 weeks visit.
|
Dispense
|
|
Visual Acuity
Délai: 2 Weeks
|
Objective measurement by investigator of monocular high and low contrast logMar visual acuity.
Visual Acuity High-Contrast (VA HC), Visual Acuity Low-Contrast (VA LC), Visual Acuity High-Contrast OU (VA HC OU), Visual Acuity Low-Contrast OU (VA LC OU).
Obtained at 2 weeks.
|
2 Weeks
|
|
Anterior Ocular Physiological Response
Délai: Baseline
|
Ocular response assessed with the slit lamp using a Visual Analog Scale (0-4, 0=none, 4=severe).
Obtained for habitual lenses at baseline.
|
Baseline
|
|
Anterior Ocular Physiological Response
Délai: 2 Weeks
|
Ocular response assessed with the slit lamp using a Visual Analog Scale (0-4, 0=none, 4=severe).
Obtained at 2 weeks.
|
2 Weeks
|
|
Average Wearing Time
Délai: Baseline
|
Participant response when asked, "Number of hours worn today?" (hours per day) Obtained for habitual lens at baseline.
|
Baseline
|
|
Average Wearing Time
Délai: 2 Weeks
|
Participant response when asked, "Number of hours worn today?" (hours per day) Obtained at 2 weeks.
|
2 Weeks
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Les enquêteurs
- Chercheur principal: Lyndon Jones, CCLR, University of Waterloo
- Chercheur principal: Meng Lin, CRC, University of California Berkeley
- Chercheur principal: Jan Bergmanson, TERTC, University of Houston
- Chercheur principal: Pete Kollbaum, CORL, Indiana University
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude
1 octobre 2013
Achèvement primaire (Réel)
1 avril 2014
Achèvement de l'étude (Réel)
1 décembre 2014
Dates d'inscription aux études
Première soumission
6 février 2014
Première soumission répondant aux critères de contrôle qualité
10 février 2014
Première publication (Estimation)
12 février 2014
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
11 décembre 2017
Dernière mise à jour soumise répondant aux critères de contrôle qualité
8 novembre 2017
Dernière vérification
1 juin 2015
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- CV-13-47
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
produit fabriqué et exporté des États-Unis.
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .